Acurx Pharmaceuticals Inc (ACXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,556 | 5,907 | 6,064 | 4,644 | 3,707 |
| Receivables | 48 | 40 | 40 | N/A | 51 |
| TOTAL | $7,690 | $6,105 | $6,158 | $4,806 | $3,858 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $7,690 | $6,105 | $6,158 | $4,806 | $3,858 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,421 | 2,468 | 2,592 | 2,494 | 3,243 |
| TOTAL | $2,421 | $2,468 | $2,592 | $2,494 | $3,243 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,421 | $2,468 | $2,592 | $2,494 | $3,243 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,855 | 2,085 | 1,585 | 1,174 | 1,102 |
| Common Shares | 2 | 2 | 2 | 22 | 1 |
| Retained earnings | -75,289 | -73,710 | -71,717 | -69,471 | -67,322 |
| TOTAL | $5,269 | $3,637 | $3,566 | $2,311 | $615 |
| Total Liabilities And Equity | $7,690 | $6,105 | $6,158 | $4,806 | $3,858 |